FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
9 letters match. Newest first.
-
DevicesShenzhen Moyeah Intelligent Life Technology Co.
Shenzhen Moyeah sold ozone and UV CPAP cleaner and sanitizer devices in the U.S. without FDA clearance or approval, FDA says.
High risk -
DevicesNatures Pillows, Inc. and Top Dog Direct, LLC
FDA warns Natures Pillows and Top Dog Direct that Clean Zone CPAP Sanitizer is an unapproved, misbranded device.
High risk -
DevicesSpectrum Medical Ltd
Spectrum Medical marketed Quantum perfusion devices beyond cleared uses and had corrective-action failures.
High risk -
DevicesNeurotris, Inc. dba A1 Engineering
FDA warns Neurotris over unapproved, misbranded facial/body stimulator devices and quality system violations.
High risk -
DevicesKing Systems Corp. dba Ambu, Inc.
FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.
High risk -
DevicesOutset Medical, Inc.
FDA warns Outset Medical over unapproved TabloCart and promotion of Tablo dialysis system for unapproved CRRT use.
High risk -
DevicesCreativeStar Solutions
CreativeStar Solutions offered Artemis thermal scanners for sale online with claims they prevent COVID-19, unapproved by FDA.
High risk -
DevicesThermavis
FDA warned UK firm Thermavis that it sells an uncleared thermal screening camera with COVID-19 claims, calling the product adulterated and misbranded.
High risk -
DevicesDubak Electrical Group
FDA warned Dubak Electrical Group that its DuThermX temperature-screening device was illegally marketed for COVID-19 use.
High risk